Interferon-γ orchestrates leptomeningeal anti-tumour response.
| Publication Type | Academic Article |
| Authors | Remsik J, Tong X, Kunes R, Li M, Estrera R, Snyder J, Thomson C, Osman A, Chabot K, Sener U, Wilcox J, Isakov D, Wang H, Bale T, Chaligné R, Sun J, Brown C, Pe'er D, Boire A |
| Journal | Nature |
| Volume | 643 |
| Issue | 8073 |
| Pagination | 1087-1096 |
| Date Published | 05/14/2025 |
| ISSN | 1476-4687 |
| Keywords | Interferon-gamma, Meningeal Neoplasms, Meninges |
| Abstract | Metastasis to the cerebrospinal-fluid-filled leptomeninges, or leptomeningeal metastasis, represents a fatal complication of solid tumours1. Multimodal analyses of clinical specimens reveal substantial inflammatory infiltrate in leptomeningeal metastases with enrichment of IFNγ and resulting downstream signalling. Here, to investigate and overcome this futile anti-tumour response within the leptomeninges, we developed syngeneic lung cancer, breast cancer and melanoma leptomeningeal-metastasis mouse models. We show that transgenic host mice lacking IFNγ or its receptor fail to control the growth of leptomeningeal metastases growth. Leptomeningeal overexpression of Ifng through a targeted adeno-associated-virus-based system controls cancer cell growth independent of adaptive immunity. Using a suite of transgenic hosts, we demonstrate that leptomeningeal T cells generate IFNγ to actively recruit and activate peripheral myeloid cells, generating a diverse spectrum of dendritic cell subsets. Independent of antigen presentation, migratory CCR7+ dendritic cells orchestrate the influx, proliferation and cytotoxic action of natural killer cells to control cancer cell growth in the leptomeninges. This study identifies unique, leptomeninges-specific IFNγ signalling and suggests an immune-therapeutic approach against tumours within this space. |
| DOI | 10.1038/s41586-025-09012-z |
| PubMed ID | 40369076 |
| PubMed Central ID | PMC12286854 |